Estrogen receptor signaling and its relationship to cytokines in systemic lupus erythematosus

Journal of Biomedicine and Biotechnology

Volumn 2010, Issue , 2010, Pages

  Kassi, E ^a,b   Moutsatsou, P ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CD16 ANTIGEN; CYTOKINE; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; G PROTEIN COUPLED RECEPTOR 30; GAMMA INTERFERON; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; MITOCHONDRIAL ENZYME; TAMOXIFEN; TRANSCRIPTION FACTOR NFAT; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN EXPRESSION; CD4+ T LYMPHOCYTE; CELL MEMBRANE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DNA POLYMORPHISM; GENE ACTIVATION; GENE CONTROL; GENETIC CORRELATION; GENETIC TRANSCRIPTION; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; MOLECULAR BIOLOGY; PERIPHERAL BLOOD MONONUCLEAR CELL; RECEPTOR GENE; REVIEW; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; HUMAN; METABOLISM;

CYTOKINES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION;

EID: 77954553349     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2010/317452     Document Type: Review

References (176)

1. Zhang J., Jacobi A. M., Wang T., Berlin R., Volpe B. T., Diamond B., Polyreactive autoantibodies in systemic lupus erythematosus have pathogenic potential Journal of Autoimmunity 2009 33 270 274
2. Tenbrock K., Juang Y.-T., Kyttaris V. C., Tsokos G. C., Altered signal transduction in SLE T cells Rheumatology 2007 46 10 1525 1530
3. Boumpas D. T., Fessler B. J., Austin H. A. III, Balow J. E., Klippel J. H., Lockshin M. D., Systemic lupus erythematosus: emerging conceptspart 2: dermatologic and joint disease, the antiphospholipid antibody syndrome, pregnancy and hormonal therapy, morbidity and mortality, and pathogenesis Annals of Internal Medicine 1995 123 1 42 53
4. Lourenco E. V., La C. A., Cytokines in systemic lupus erythematosus Current Molecular Medicine 2009 9 242 254
5. Kulkarni O., Anders H.-J., Chemokines in lupus nephritis Frontiers in Bioscience 2008 13 9 3312 3320
6. Linker-Israeli M., Deans R. J., Wallace D. J., Prehn J., Ozeri-Chen T., Klinenberg J. R., Elevated levels of endogenous IL-6 in systemic lupus erythematosus: a putative role in pathogenesis The Journal of Immunology 1991 147 1 117 123
7. Viallard J.-F., Pellegrin J. L., Ranchin V., Th1 (IL-2, interferon- (IFN- )) and Th2 (IL-10, IL-4) cytokine production by peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE) Clinical and Experimental Immunology 1999 115 1 189 195
8. Hagiwara E., Gourley M. F., Lee S., Klinman D. M., Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of interleukin-10:interferon- -secreting cells in the peripheral blood Arthritis and Rheumatism 1996 39 3 379 385
9. Houssiau F. A., Lefebvre C., Vanden Berghe M., Lambert M., Devogelaer J.-P., Renauld J.-C., Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity Lupus 1995 4 5 393 395
10. Llorente L., Zou W., Levy Y., Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus Journal of Experimental Medicine 1995 181 3 839 844
11. Diehl S., Rincn M., The two faces of IL-6 on Th1/Th2 differentiation Molecular Immunology 2002 39 9 531 536
12. Al-Janadi M., Al-Balla S., Al-Dalaan A., Raziuddin S., Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis, and other rheumatic diseases Journal of Clinical Immunology 1993 13 1 58 67
13. Studnicka-Benke A., Steiner G., Petera P., Smolen J. S., Tumour necrosis factor and its soluble receptors parallel clinical disease and autoimmune activity in systemic lupus erythematosus British Journal of Rheumatology 1996 35 11 1067 1074
14. Gabay C., Cakir N., Moral F., Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity Journal of Rheumatology 1997 24 2 303 308
15. Mageed R. A., Isenberg D. A., Tumour necrosis factor in systemic lupus erythematosus and anti-DNA autoantibody production Lupus 2002 11 12 850 855
16. Cervera R., Khamashta M. A., Font J., Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus Medicine 1993 72 113 124
17. Lahita R. G., The role of sex hormones in systemic lupus erythematosus Current Opinion in Rheumatology 1999 11 5 352 356
18. Michnovicz J. J., Bradlow H. L., Altered estrogen metabolism and excretion in humans following consumption of indole-3-carbinol Nutrition and Cancer 1991 16 1 59 66
19. Lahita R. G., Bradlow H. L., Kunkel H. G., Fishman J., Alterations of estrogen metabolism in systemic lupus erythematosus Arthritis and Rheumatism 1979 22 11 1195 1198 (Pubitemid 10163784)
20. Doria A., Iaccarino L., Sarzi-Puttini P., Estrogens in pregnancy and systemic lupus erythematosus Annals of the New York Academy of Sciences 2006 1069 247 256
21. Baer A. N., Green F. A., Estrogen metabolism in the (New Zealand black New Zealand white) F1 murine model of systemic lupus erythematosus Arthritis and Rheumatism 1990 33 1 107 112
22. Lahita R. G., Sex steroids and the rheumatic diseases Arthritis and Rheumatism 1985 28 2 121 126
23. Culwell K. R., Curtis K. M., del Carmen Cravioto M., Safety of contraceptive method use among women with systemic lupus erythematosus: a systematic review Obstetrics and Gynecology 2009 114 2, part 1 341 353
24. Askanase A. D., Estrogen therapy in systemic lupus erythematosus Treatments in Endocrinology 2004 3 1 19 26
25. Buyon J. P., Petri M. A., Kim M. Y., The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial Annals of Internal Medicine 2005 142 12 953 962
26. Snchez-Guerrero J., Gonzlez-Prez M., Durand-Carbajal M., Menopause hormonal therapy in women with systemic lupus erythematosus Arthritis and Rheumatism 2007 56 9 3070 3079
27. Mok C. C., Lau C. S., Ho C. T. K., Safety of hormonal replacement therapy in postmenopausal patients with systemic lupus erythematosus Scandinavian Journal of Rheumatology 1998 27 5 342 346
28. Yung R. L., Mechanisms of lupus: the role of estrogens Clinical and Experimental Rheumatology 1999 17 3 271 275
29. Cohen-Solal J. F. G., Jeganathan V., Grimaldi C. M., Peeva E., Diamond B., Sex hormones and SLE: influencing the fate of autoreactive B Cells Current Topics in Microbiology and Immunology 2006 305 67 88
30. Straub R. H., The complex role of estrogens in inflammation Endocrine Reviews 2007 28 5 521 574
31. Greene G. L., Gilna P., Waterfield M., Baker A., Hort Y., Shine J., Sequence and expression of human estrogen receptor complementary DNA Science 1986 231 1150 1154
32. Mosselman S., Polman J., Dijkema R., ER : identification and characterization of a novel human estrogen receptor FEBS Letters 1996 392 1 49 53
33. Evans R. M., The steroid and thyroid hormone receptor superfamily Science 1988 240 4854 889 895
34. Matthews J., Gustafsson J. A., Estrogen signaling: a subtle balance between ER and ER Molecular Interventions 2003 3 5 281 292
35. Moore J. T., McKee D. D., Slentz-Kesler K., Cloning and characterization of human estrogen receptor isoforms Biochemical and Biophysical Research Communications 1998 247 1 75 78
36. Mason C. E., Shu F. J., Wang C., Location analysis for the estrogen receptor- reveals binding to diverse ERE sequences and widespread binding within repetitive DNA elements Nucleic Acids Research 2010 38 7 2355 2368
37. Beato M., Herrlich P., Schtz G., Steroid hormone receptors: many actors in search of a plot Cell 1995 83 6 851 857
38. Horwitz K. B., Jackson T. A., Bain D. L., Richer J. K., Takimoto G. S., Tung L., Nuclear receptor coactivators and corepressors Molecular Endocrinology 1996 10 10 1167 1177
39. Lee K. C., Kraus W. L., Nuclear receptors, coactivators and chromatin: new approaches, new insights Trends in Endocrinology and Metabolism 2001 12 5 191 197
40. Freedman L. P., Increasing the complexity of coactivation in nuclear receptor signaling Cell 1999 97 1 5 8
41. Wolffe A. P., Chromatin remodeling regulated by steroid and nuclear receptors Cell Research 1997 7 2 127 142
42. Wolffe A. P., Hayes J. J., Chromatin disruption and modification Nucleic Acids Research 1999 27 3 711 720
43. Cerillo G., Rees A., Manchanda N., The oestrogen receptor regulates NF B and AP-1 activity in a cell-specific manner Journal of Steroid Biochemistry and Molecular Biology 1998 67 2 79 88
44. Paech K., Webb P., Kuiper G. G. J. M., Differential ligand activation of estrogen receptors ER and ERr at AP1 sites Science 1997 277 5331 1508 1510
45. Webb P., Lopez G. N., Uht R. M., Kushner P. J., Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens Molecular Endocrinology 1995 9 4 443 456
46. McKay L. I., Cidlowski J. A., Molecular control of immune/inflammatory responses: interactions between nuclear factor- B and steroid receptor-signaling pathways Endocrine Reviews 1999 20 4 435 459
47. Pfeilschifter J., Kditz R., Pfohl M., Schatz H., Changes in proinflammatory cytokine activity after menopause Endocrine Reviews 2002 23 1 90 119
48. Kato S., Endoh H., Masuhiro Y., Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase Science 1995 270 5241 1491 1494
49. Zwijsen R. M. L., Wientjens E., Klompmaker R., van der Sman J., Bernards R., Michalides R.J.A.M., CDK-independent activation of estrogen receptor by cyclin D1 Cell 1997 88 3 405 415
50. Nilsson S., Mkel S., Treuter E., Mechanisms of estrogen action Physiological Reviews 2001 81 4 1535 1565
51. Picard N., Charbonneau C., Sanchez M., Phosphorylation of activation function-1 regulates proteasome-dependent nuclear mobility and E6-associated protein ubiquitin ligase recruitment to the estrogen receptor Molecular Endocrinology 2008 22 2 317 330
52. Sauve K., Lepage J., Sanchez M., Heveker N., Tremblay A., Positive feedback activation of estrogen receptors by the CXCL12-CXCR4 pathway Cancer Research 2009 69 14 5793 5800
53. Pedram A., Razandi M., Levin E. R., Nature of functional estrogen receptors at the plasma membrane Molecular Endocrinology 2006 20 9 1996 2009 (Pubitemid 44286700)
54. Li L., Haynes M. P., Bender J. R., Plasma membrane localization and function of the estrogen receptor variant (ER46) in human endothelial cells Proceedings of the National Academy of Sciences of the United States of America 2003 100 8 4807 4812
55. Doolan C. M., Harvey B. J., A G s protein-coupled membrane receptor, distinct from the classical oestrogen receptor, transduces rapid effects of oestradiol on [Ca2+] in female rat distal colon Molecular and Cellular Endocrinology 2003 199 1-2 87 103
56. Razandi M., Pedram A., Greene G. L., Levin E. R., Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: studies of ER and ER expressed in Chinese hamster ovary cells Molecular Endocrinology 1999 13 307 319
57. Song R. X., Barnes C. J., Zhang Z., Bao Y., Kumar R., Santen R.J., The role of Shc and insulin-like growth factor 1 receptor in mediating the translocation of estrogen receptor to the plasma membrane Proceedings of the National Academy of Sciences of the United States of America 2004 101 7 2076 2081
58. Acconcia F., Ascenzi P., Bocedi A., Palmitoylation-dependent estrogen receptor membrane localization: regulation by 17 -estradiol Molecular Biology of the Cell 2005 16 1 231 237
59. Thomas P., Pang Y., Filardo E. J., Dong J., Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells Endocrinology 2005 146 2 624 632
60. Prossnitz E. R., Arterburn J. B., Smith H. O., Oprea T. I., Sklar L. A., Hathaway H. J., Estrogen signaling through the transmembrane G protein-coupled receptor GPR30 Annual Review of Physiology 2008 70 165 190
61. Simoncini T., Hafezi-Moghadam A., Brazil D. P., Ley K., Chin W. W., Liao J. K., Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase Nature 2000 407 6803 538 541
62. Filardo E. J., Quinn J. A., Bland K. I., Frackelton A. R. Jr., Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF Molecular Endocrinology 2000 14 10 1649 1660
63. Revankar C. M., Cimino D. F., Sklar L. A., Arterburn J. B., Prossnitz E. R., A transmembrane intracellular estrogen receptor mediates rapid cell signaling Science 2005 307 5715 1625 1630
64. Stefano G. B., Peter D., Cell surface estrogen receptors coupled to cNOS mediate immune and vascular tissue regulation: therapeutic implications Medical Science Monitor 2001 7 1066 1074
65. Benten W. P. M., Becker A., Schmitt-Wrede H.-P., Wunderlich F., Developmental regulation of intracellular and surface androgen receptors in T cells Steroids 2002 67 11 925 931 (Pubitemid 35286749)
66. Simpkins J. W., Yang S.-H., Sarkar S. N., Pearce V., Estrogen actions on mitochondria-physiological and pathological implications Molecular and Cellular Endocrinology 2008 290 1-2 51 59
67. Scheller K., Sekeris C. E., The effects of steroid hormones on the transcription of genes encoding enzymes of oxidative phosphorylation Experimental Physiology 2003 88 1 129 140
68. Bettini E., Maggi A., Estrogen induction of cytochrome c oxidase subunit III in rat hippocampus Journal of Neurochemistry 1992 58 5 1923 1929
69. Van Itallie C. M., Dannies P. S., Estrogen induces accumulation of the mitochondrial ribonucleic acid for subunit II of cytochrome oxidase in pituitary tumor cells Molecular Endocrinology 1988 2 4 332 337
70. Chen J.-Q., Cammarata P. R., Baines C. P., Yager J. D., Regulation of mitochondrial respiratory chain biogenesis by estrogens/estrogen receptors and physiological, pathological and pharmacological implications Biochimica et Biophysica Acta 2009 1793 10 1540 1570
71. Sekeris C. E., The mitochondrial genome: a possible primary site of actin of steroid hormones In Vivo 1990 4 5 317 320
72. Demonacos C. V., Karayanni N., Hatzoglou E., Tsiriyiotis C., Spandidos D. A., Sekeris C. E., Mitochondrial genes as sites of primary action of steroid hormones Steroids 1996 61 4 226 232
73. Chen J. Q., Eshete M., Alworth W. L., Yager J. D., Binding of MCF-7 cell mitochondrial proteins and recombinant human estrogen receptors and to human mitochondrial DNA estrogen response elements Journal of Cellular Biochemistry 2004 93 2 358 373
74. Chen J.-Q., Russo P. A., Cooke C., Russo I. H., Russo J., ER shifts from mitochondria to nucleus during estrogen-induced neoplastic transformation of human breast epithelial cells and is involved in estrogen-induced synthesis of mitochondrial respiratory chain proteins Biochimica et Biophysica Acta 2007 1773 12 1732 1746
75. Gergely P. Jr., Grossman C., Niland B., Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus Arthritis and Rheumatism 2002 46 1 175 190
76. Perl A., Gergely P. Jr., Nagy G., Koncz A., Banki K., Mitochondrial hyperpolarization: a checkpoint of T-cell life, death and autoimmunity Trends in Immunology 2004 25 7 360 367
77. Li Q., Ward J., Banerjee S., Perl A., Prominent changes in expression of Ca2+ fluxing, mitochondrial electron transport, and antioxidant pathway genes in peripheral blood lymphocytes of patients with systemic lupus erythematosus Arthritis and Rheumatism 2005 52 S617
78. Vyshkina T., Sylvester A., Sadiq S., Association of common mitochondrial DNA variants with multiple sclerosis and systemic lupus erythematosus Clinical Immunology 2008 129 1 31 35
79. Tsokos G. C., Kammer G. M., Molecular aberrations in human systemic lupus erythematosus Molecular Medicine Today 2000 6 11 418 424
80. Pernis A. B., Estrogen and CD4+ T cells Current Opinion in Rheumatology 2007 19 5 414 420
81. Mevorach D., Perrot S., Buchanan N. M. M., Appearance of systemic lupus erythematosus after thymectomy: four case reports and review of the literature Lupus 1995 4 1 33 37
82. Gutierrez-Ramos J. C., Andreu J. L., Revilla Y., Vinuela E., Martinez A. C., Recovery from autoimmunity of MRL/lpr mice after infection with an interleukin-2/vaccinia recombinant virus Nature 1990 346 6281 271 274
83. Stimson W. H., Hunter I. C., Oestrogen-induced immunoregulation mediated through the thymus Journal of Clinical and Laboratory Immunology 1980 4 1 27 33
84. Ryan M. R., Shepherd R., Leavey J. K., An IL-7-dependent rebound in thymic T cell output contributes to the bone loss induced by estrogen deficiency Proceedings of the National Academy of Sciences of the United States of America 2005 102 46 16735 16740
85. Staples J. E., Gasiewicz T. A., Fiore N. C., Lubahn D. B., Korach K. S., Silverstone A. E., Estrogen receptor is necessary in thymic development and estradiol-induced thymic alterations The Journal of Immunology 1999 163 8 4168 4174
86. Cohen J. H. M., Danel L., Cordier G., Saez S., Revillard J. P., Sex steroid receptors in peripheral T cells: absence of androgen receptors and restriction of estrogen receptors to OKT8-positive cells The Journal of Immunology 1983 131 6 2767 2771
87. Suenaga R., Evans M. J., Mitamura K., Rider V., Abdou N. I., Peripheral blood T cells and monocytes and B cell lines derived from patients with lupus express estrogen receptor transcripts similar to those of normal cells Journal of Rheumatology 1998 25 7 1305 1312
88. Maret A., Coudert J. D., Garidou L., Estradiol enhances primary antigen-specific CD4 T cell responses and Th1 development in vivo. Essential role of estrogen receptor expression in hematopoietic cells European Journal of Immunology 2003 33 2 512 521
89. Bao M., Yang Y., Jun H.-S., Yoon J.-W., Molecular mechanisms for gender differences in susceptibility to T cell-mediated autoimmune diabetes in nonobese diabetic mice The Journal of Immunology 2002 168 10 5369 5375
90. Buyon J. P., The effects of pregnancy on autoimmune diseases Journal of Leukocyte Biology 1998 63 3 281 287
91. Krishnan L., Guilbert L. J., Russell A. S., Wegmann T. G., Mosmann T. R., Belosevic M., Pregnancy impairs resistance of C57BL/6 mice to Leishmania major infection and causes decreased antigen-specific IFN- responses and increased production of T helper 2 cytokines The Journal of Immunology 1996 156 2 644 652
92. Salem M. L., Estrogen, a double-edged sword: modulation of TH1- and TH2-mediated inflammations by differential regulation of TH1/TH2 cytokine production Current Drug Targets: Inflammation and Allergy 2004 3 1 97 104
93. Gilmore W., Weiner L. P., Correale J., Effect of estradiol on cytokine secretion by proteolipid protein-specific T cell clones isolated from multiple sclerosis patients and normal control subjects The Journal of Immunology 1997 158 1 446 451
94. Correale J., Arias M., Gilmore W., Steroid hormone regulation of cytokine secretion by proteolipid protein-specific CD4+ T cell clones isolated from multiple sclerosis patients and normal control subjects The Journal of Immunology 1998 161 7 3365 3374
95. Zang Y. C. Q., Halder J. B., Hong J., Rivera V. M., Zhang J. Z., Regulatory effects of estriol on T cell migration and cytokine profile: inhibition of transcription factor NF- B Journal of Neuroimmunology 2002 124 1-2 106 114
96. Lambert K. C., Curran E. M., Judy B. M., Milligan G. N., Lubahn D. B., Estes D. M., Estrogen receptor (ER ) deficiency in macrophages results in increased stimulation of CD4+ T cells while 17 -estradiol acts through ER to increase IL-4 and GATA-3 expression in CD4+ T cells independent of antigen presentation The Journal of Immunology 2005 175 5716 5723
97. Kamada M., Irahara M., Maegawa M., Transient increase in the levels of T-helper 1 cytokines in postmenopausal women and the effects of hormone replacement therapy Gynecologic and Obstetric Investigation 2001 52 2 82 88 (Pubitemid 34701593)
98. Kumru S., Godekmerdan A., Yilmaz B., Immune effects of surgical menopause and estrogen replacement therapy in peri-menopausal women Journal of Reproductive Immunology 2004 63 1 31 38
99. McMurray R. W., Ndebele K., Hardy K. J., Jenkins J. K., 17- -estradiol suppresses IL-2 and IL-2 receptor Cytokine 2001 14 6 324 333
100. Xia X., Zhang S., Yu Y., Effects of estrogen replacement therapy on estrogen receptor expression and immunoregulatory cytokine secretion in surgically induced menopausal women Journal of Reproductive Immunology 2009 81 89 96
101. Suzuki T., Shimizu T., Yu H. P., Hsieh Y. C., Choudhry M. A., Chaudry I. H., Salutary effects of 17 -estradiol on T-cell signaling and cytokine production after trauma hemorrhage are mediated primarily via estrogen receptor- American Journal of Physiology 2007 292 C2103 C2111
102. Segal R., Dayan M., Zinger H., Habut B., Shearer G. M., Mozes E., The effect of IL-12 on clinical and laboratory aspects of experimental SLE in young and aging mice Experimental Gerontology 2003 38 6 661 668
103. Polan M. L., Daniele A., Kuo A., Gonadal steroids modulate human monocyte interleukin-1 (IL-1) activity Fertility and Sterility 1988 49 6 964 968
104. Steinman L., A brief history of TH17, the first major revision in the TH1 / TH2 hypothesis of T cell-mediated tissue damage Nature Medicine 2007 13 2 139 145
105. Nalbandian A., Crispin J. C., Tsokos G. C., Interleukin-17 and systemic lupus erythematosus: current concepts Clinical and Experimental Immunology 2009 157 209 215
106. Wang C., Dehghani B., Li Y., Kaler L. J., Vandenbark A. A., Offner H., Oestrogen modulates experimental autoimmune encephalomyelitis and interleukin-17 production via programmed death 1 Immunology 2009 126 3 329 335
107. Wang C., Dehghani B., Li Y., Membrane estrogen receptor regulates experimental autoimmune encephalomyelitis through upregulation of programmed death 1 The Journal of Immunology 2009 182 3294 3303
108. Rogers A., Eastell R., The effect of 17 -estradiol on production of cytokines in cultures of peripheral blood Bone 2001 29 1 30 34
109. Rachon D., Mysliwska J., Suchecka-Rachon K., Wieckiewicz J., Mysliwski A., Effects of oestrogen deprivation on interleukin-6 production by peripheral blood mononuclear cells of postmenopausal women Journal of Endocrinology 2002 172 2 387 395
110. Kube D., Platzer C., von Knethen A., Isolation of the human interleukin 10 promoter. Characterization of the promoter activity in Burkitt's lymphoma cell lines Cytokine 1995 7 1 1 7
111. Fox H. S., Bond B. L., Parslow T. G., Estrogen regulates the IFN- promoter The Journal of Immunology 1991 146 12 4362 4367
112. Baeuerle P. A., Henkel T., Function and activation of NF- B in the immune system Annual Review of Immunology 1994 12 141 179
113. Liu J., Beller D. I., Distinct pathways for NF- B regulation are associated with aberrant macrophage IL-12 production in lupus- and diabetes-prone mouse strains The Journal of Immunology 2003 170 9 4489 4496
114. Katsiari C. G., Tsokos G. C., Transcriptional repression of interleukin-2 in human systemic lupus erythematosus Autoimmunity Reviews 2006 5 2 118 121
115. Tsokos G. C., Wong H. K., Enyedy E. J., Nambiar M. P., Immune cell signaling in lupus Current Opinion in Rheumatology 2000 12 5 355 363
116. Rao A., NF-ATp: a transcription factor required for the co-ordinate induction of several cytokine genes Immunology Today 1994 15 6 274 281
117. Schwartz R. H., Costimulation of T lymphocytes: The role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy Cell 1992 71 7 1065 1068
118. Wong H. K., Kammer G. M., Dennis G., Tsokos G. C., Abnormal NF- B activity in T lymphocytes from patients with systemic lupus erythematosus is associated with decreased p65-RelA protein expression The Journal of Immunology 1999 163 3 1682 1689
119. Burgos P., Metz C., Bull P., Increased expression of c-rel, from the NF- B/Rel family, in T cells from patients with systemic lupus erythematosus Journal of Rheumatology 2000 27 1 116 127
120. Herndon T. M., Juang Y.-T., Solomou E. E., Rothwell S. W., Gourley M. F., Tsokos G. C., Direct transfer of p65 into T lymphocytes from systemic lupus erythematosus patients leads to increased levels of interleukin-2 promoter activity Clinical Immunology 2002 103 2 145 153
121. Oikonomidou O., Vlachoyiannopoulos P. G., Kominakis A., Kalofoutis A., Moutsopoulos H. M., Moutsatsou P., Glucocorticoid receptor, nuclear factor B, activator protein- 1 and C-jun N-terminal kinase in systemic lupus erythematosus patients Neuroimmunomodulation 2006 13 194 204
122. Wong H. K., Kammer G. M., Mishra N., Dennis G., Tsokos G. C., Activator protein-1(AP-1) regulation in lymphocytes from patients with systemic lupus erythematosus Arthritis and Rheumatism 1999 42 S312
123. Solomou E. E., Juang Y.-T., Gourley M. F., Kammer G. M., Tsokos G. C., Molecular basis of deficient IL-2 production in T cells from patients with systemic lupus erythematosus The Journal of Immunology 2001 166 6 4216 4222
124. Kyttaris V. C., Juang Y.-T., Tenbrock K., Weinstein A., Tsokos G. C., Cyclic adenosine 5'-monophosphate response element modulator is responsible for the decreased expression of c-fos, and activator protein-1 binding in T cells from patients with systemic lupus erythematosus The Journal of Immunology 2004 173 5 3557 3563
125. Hirano S., Furutama D., Hanafusa T., Physiologically high concentrations of 17 -estradiol enhance NF- B activity in human T cells American Journal of Physiology 2007 292 4 R1465 R1471
126. Calippe B., Douin-Echinard V., Laffargue M., Chronic estradiol administration in vivo promotes the proinflammatory response of macrophages to TLR4 activation: involvement of the phosphatidylinositol 3-kinase pathway The Journal of Immunology 2008 180 12 7980 7988
127. Ding D., Mehta H., McCune W. J., Kaplan M. J., Aberrant phenotype and function of myeloid dendritic cells in systemic lupus erythematosus The Journal of Immunology 2006 177 9 5878 5889
128. Decker P., Ktter I., Klein R., Berner B., Rammensee H.-G., Monocyte-derived dendritic cells over-express CD86 in patients with systemic lupus erythematosus Rheumatology 2006 45 9 1087 1095
129. Douin-Echinard V., Laffont S., Seillet C., Estrogen receptor, but not, is required for optimal dendritic cell differentiation and [corrected] CD40-induced cytokine production The Journal of Immunology 2008 180 3661 3669
130. Kanda N., Tsuchida T., Tamaki K., Estrogen enhancement of anti-double-stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus Arthritis and Rheumatism 1999 42 2 328 337
131. Kramer P. R., Kramer S. F., Guan G., 17 -estradiol regulates cytokine release through modulation of CD16 expression in monocytes and monocyte-derived macrophages Arthritis and Rheumatism 2004 50 1967 1975
132. Pottratz S. T., Bellido T., Mocharla H., Crabb D., Manolagas S. C., 17 -Estradiol inhibits expression of human interleukin-6 promoter-reporter constructs by a receptordependent mechanism The Journal of Clinical Investigation 1994 93 944 950
133. Srivastava S., Weitzmann M. N., Cenci S., Ross F. P., Adler S., Pacifici R., Estrogen decreases TNF gene expression by blocking JNK activity and the resulting production of c-Jun and JunD The Journal of Clinical Investigation 1999 104 4 503 513
134. Krieg S. A., Krieg A. J., Shapiro D. J., A unique downstream estrogen responsive unit mediates estrogen induction of proteinase inhibitor-9, a cellular inhibitor of IL-1- converting enzyme (caspase 1) Molecular Endocrinology 2001 15 11 1971 1982
135. Cutolo M., Montagna P., Brizzolara R., Sex hormones modulate the effects of Leflunomide on cytokine production by cultures of differentiated monocyte/macrophages and synovial macrophages from rheumatoid arthritis patients Journal of Autoimmunity 2009 32 3-4 254 260
136. Evans M. J., MacLaughlin S., Marvin R. D., Abdou N. I., Estrogen decreases in vitro apoptosis of peripheral blood mononuclear cells from women with normal menstrual cycles and decreases TNF- production in SLE but not in normal cultures Clinical Immunology and Immunopathology 1997 82 3 258 262
137. Rider V., Foster R. T., Evans M., Suenaga R., Abdou N. I., Gender differences in autoimmune diseases: estrogen increases calcineurin expression in systemic lupus erythematosus Clinical Immunology and Immunopathology 1998 89 2 171 180
138. Liu J., Farmer J. D. Jr., Lane W. S., Friedman J., Weissman I., Schreiber S. L., Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes Cell 1991 66 4 807 815
139. Bierer B. E., Hollander G., Fruman D., Burakoff S. J., Cyclosporin A and FK506: molecular mechanisms of immunosuppression and probes for transplantation biology Current Opinion in Immunology 1993 5 5 763 773
140. Liu J., Koyano-Nakagawa N., Amasaki Y., Calcineurin-dependent nuclear translocation of a murine transcription factor NFATx: molecular cloning and functional characterization Molecular Biology of the Cell 1997 8 1 157 170 (Pubitemid 27294805)
141. Jain J., McCaffrey P. G., Miner Z., The Tcell transcription factor NFATp is a substrate for calcineurin and interacts with Fos and Jun Nature 1993 365 352 355
142. Tsytsykova A. V., Tsitsikov E. N., Geha R. S., The CD40L promoter contains nuclear factor of activated T cells-binding motifs which require AP-1 binding for activation of transcription Journal of Biological Chemistry 1996 271 7 3763 3770
143. Crow M. K., Kirou K. A., Regulation of CD40 ligand expression in systemic lupus erythematosus Current Opinion in Rheumatology 2001 13 5 361 369
144. Desai-Mehta A., Lu L., Ramsey-Goldman R., Datta S. K., Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production The Journal of Clinical Investigation 1996 97 9 2063 2073
145. Yazdany J., Davis J., The role of CD40 ligand in systemic lupus erythematosus Lupus 2004 13 5 377 380
146. Thanos D., Maniatis T., NF- B: a lesson in family values Cell 1995 80 4 529 532
147. Rider V., Jones S., Evans M., Bassiri H., Afsar Z., Abdou N. I., Estrogen increases CD40 ligand expression in T cells from women with systemic lupus erythematosus Journal of Rheumatology 2001 28 12 2644 2649
148. Abdou N. I., Rider V., Greenwell C., Li X., Kimler B. F., Fulvestrant (Faslodex), an estrogen selective receptor downregulator, in therapy of women with systemic lupus erythematosus. Clinical, serologic, bone density, and T cell activation marker studies: a double-blind placebo-controlled trial Journal of Rheumatology 2008 35 5 797 803
149. Verthelyi D., Petri M., Ylamus M., Klinman D. M., Disassociation of sex hormone levels and cytokine production in SLE patients Lupus 2001 10 5 352 358
150. Doria A., Ghirardello A., Iaccarino L., Pregnancy, cytokines, and disease activity in systemic lupus erythematosus Arthritis Care and Research 2004 51 6 989 995
151. Lee H. M., Mima T., Sugino H., Interactions among type I and type II interferon, tumor necrosis factor, and -estradiol in the regulation of immune response-related gene expressions in systemic lupus erythematosus Arthritis Research Therapy 2009 11 R1
152. Howie J. B., Helyer B. J., Autoimmune disease in mice Annals of the New York Academy of Sciences 1965 124 1 167 177
153. Howie J. B., Helyer B. J., The immunology and pathology of NZB mice Advances in Immunology 1968 9 215 266
154. Sthoeger Z. M., Bentwich Z., Zinger H., Mozes E., The beneficial effect of the estrogen antagonist, tamoxifen, on experimental systemic lupus erythematosus Journal of Rheumatology 1994 21 12 2231 2238
155. Dayan M., Zinger H., Kalush F., The beneficial effects of treatment with tamoxifen and anti-oestradiol antibody on experimental systemic lupus erythematosus are associated with cytokine modulations Immunology 1997 90 1 101 108
156. Elbourne K. B., Keisler D., McMurray R. W., Differential effects of estrogen and prolactin on autoimmune disease in the NZB/NZW F1 mouse model of systemic lupus erythematosus Lupus 1998 7 6 420 427
157. Zuckerman S. H., Ahmari S. E., Bryan-Poole N., Evans G. F., Short L., Glasebrook A. L., Estriol: a potent regulator of TNF and IL-6 expression in a murine model of endotoxemia Inflammation 1996 20 6 581 597
158. Weusten J. J. A. M., Blankenstein M. A., Gmelig-Meyling F. H. J., Schuurman H. J., Kater L., Thijssen J. H., Presence of oestrogen receptors in human blood mononuclear cells and thymocytes Acta Endocrinologica 1986 112 3 409 414
159. Kelly R. H., Vertosick F. T. Jr., Systemic lupus erythematosus: a role for anti-receptor antibodies? Medical Hypotheses 1986 20 1 95 101
160. Athreya B. H., Rafferty J. H., Sehgal G. S., Lahita R. G., Adenohypophyseal and sex hormones in pediatric rheumatic diseases Journal of Rheumatology 1993 20 4 725 730
161. Suenaga R., Mitamura K., Evans M. J., Abdou N. I., Binding affinity and quantity of estrogen receptor in peripheral blood monocytes of patients with systemic lupus erythematosus Lupus 1996 5 3 227 231
162. Feng S., Estrogen receptor content of peripheral blood lymphocytes in patients with systemic lupus erythematosus Zhonghua Yi Xue Za Zhi 1991 71 1 1 2
163. Wilson K. B., Evans M., Abdou N. I., Presence of a variant form of the estrogen receptor in peripheral blood mononuclear cells from normal individuals and lupus patients Journal of Reproductive Immunology 1996 31 3 199 208
164. Kassi E. N., Vlachoyiannopoulos P. G., Moutsopoulos H. M., Sekeris C. E., Moutsatsou P., Molecular analysis of estrogen receptor and in lupus patients European Journal of Clinical Investigation 2001 31 1 86 93
165. Enmark E., Pelto-Huikko M., Grandien K., Human estrogen receptor -gene structure, chromosomal localization, and expression pattern Journal of Clinical Endocrinology and Metabolism 1997 82 12 4258 4265
166. Phiel K. L., Henderson R. A., Adelman S. J., Elloso M. M., Differential estrogen receptor gene expression in human peripheral blood mononuclear cell populations Immunology Letters 2005 97 1 107 113
167. Inui A., Ogasawara H., Naito T., Estrogen receptor expression by peripheral blood mononuclear cells of patients with systemic lupus erythematosus Clinical Rheumatology 2007 26 10 1675 1678
168. Rider V., Li X., Peterson G., Dawson J., Kimler B. F., Abdou N. I., Differential expression of estrogen receptors in women with systemic lupus erythematosus Journal of Rheumatology 2006 33 6 1093 1101 (Pubitemid 43825458)
169. Saceda M., Lindsey R. K., Solomon H., Angeloni S. V., Martin M. B., Estradiol regulates estrogen receptor mRNA stability Journal of Steroid Biochemistry and Molecular Biology 1998 66 3 113 120
170. Foster C. B., Lehrnbecher T., Mol F., Host defense molecule polymorphisms influence the risk for immune-mediated complications in chronic granulomatous disease The Journal of Clinical Investigation 1998 102 12 2146 2155
171. Kassi E., Vlachoyiannopoulos P. G., Kominakis A., Kiaris H., Moutsopoulos H. M., Moutsatsou P., Estrogen receptor gene polymorphism and systemic lupus erythematosus: a possible risk? Lupus 2005 14 5 391 398
172. Johansson M., rlestig L., Mller B., Smedby T., Rantap-Dahlqvist S., Oestrogen receptor gene polymorphisms in systemic lupus erythematosus Annals of the Rheumatic Diseases 2005 64 11 1611 1617
173. Lee Y. J., Shin K. S., Kang S. W., Association of the oestrogen receptor gene polymorphisms with disease onset in systematic lupus erythematosus Annals of the Rheumatic Diseases 2004 63 10 1244 1249
174. Liu Z.-H., Cheng Z.-H., Gong R.-J., Liu H., Liu D., Li L.-S., Sex differences in estrogen receptor gene polymorphism and its association with lupus nephritis in Chinese Nephron 2002 90 2 174 180
175. Lu Z.-M., Wang Z.-E., Liu Y.-Q., Association of estrogen receptor gene polymorphisms with cytokine genes expression in systemic lupus erythematosus Croatian Medical Journal 2009 50 2 117 123
176. Svenson J. L., EuDaly J., Ruiz P., Korach K. S., Gilkeson G. S., Impact of estrogen receptor deficiency on disease expression in the NZM2410 lupus prone mouse Clinical Immunology 2008 128 2 259 268